CN Stock MarketDetailed Quotes

600513 Jiangsu Lianhuan Pharmaceutical

Watchlist
  • 10.67
  • -0.22-2.02%
Market Closed Dec 13 15:00 CST
3.05BMarket Cap21.95P/E (TTM)

Jiangsu Lianhuan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
10.87%1.64B
17.98%1.13B
17.00%528.46M
11.20%2.17B
5.04%1.48B
6.46%954.65M
11.70%451.68M
18.80%1.96B
20.71%1.41B
18.12%896.69M
Operating revenue
10.87%1.64B
17.98%1.13B
17.00%528.46M
11.20%2.17B
5.04%1.48B
6.46%954.65M
11.70%451.68M
18.80%1.96B
20.71%1.41B
18.12%896.69M
Other operating revenue
----
-88.06%1.35M
----
34.37%21.46M
----
59.70%11.28M
----
41.36%15.97M
----
-18.18%7.06M
Total operating cost
10.54%1.52B
17.39%1.04B
16.65%481.82M
14.26%2.02B
7.84%1.37B
9.40%882.11M
13.55%413.07M
18.40%1.76B
20.80%1.27B
17.97%806.35M
Operating cost
4.89%824.02M
11.60%552.2M
13.66%268.77M
23.62%1.13B
12.50%785.58M
11.61%494.79M
17.01%236.47M
22.15%912.12M
22.89%698.32M
23.61%443.31M
Operating tax surcharges
14.20%14.81M
20.88%10.55M
15.30%4.62M
8.22%19.87M
3.70%12.97M
9.47%8.73M
25.25%4M
19.59%18.36M
26.68%12.5M
26.76%7.98M
Operating expense
17.69%459.17M
19.98%320.98M
20.86%142.32M
-2.09%591.6M
2.73%390.14M
10.36%267.53M
8.24%117.76M
13.52%604.24M
14.48%379.77M
9.08%242.41M
Administration expense
9.98%106.06M
10.69%72.59M
6.34%42.47M
2.32%119.52M
-12.40%96.44M
-15.01%65.58M
3.69%39.94M
4.90%116.81M
19.14%110.09M
17.02%77.16M
Financial expense
2.43%18.23M
-3.26%11.57M
9.70%5.9M
24.29%25.48M
41.72%17.8M
76.66%11.96M
26.31%5.38M
12.68%20.5M
6.82%12.56M
1.95%6.77M
-Interest expense (Financial expense)
8.22%18.91M
-6.81%12.12M
-0.95%5.33M
5.98%26.69M
3.58%17.47M
24.64%13.01M
13.37%5.38M
31.86%25.18M
30.15%16.87M
34.57%10.44M
-Interest Income (Financial expense)
45.08%-582.09K
45.68%-447.13K
56.36%-216.13K
51.48%-1.33M
51.90%-1.06M
51.63%-823.1K
37.56%-495.25K
-41.76%-2.74M
-66.72%-2.2M
-41.23%-1.7M
Research and development
36.61%94.32M
101.59%67.58M
86.38%17.74M
42.95%132.14M
17.14%69.04M
16.70%33.52M
37.90%9.52M
39.06%92.44M
50.66%58.94M
20.69%28.73M
Credit Impairment Loss
-1,461.65%-4.98M
-155.76%-2.55M
-292.37%-2.12M
56.75%-3.71M
112.32%365.45K
60.08%-998.27K
174.81%1.1M
-610.33%-8.59M
-24.99%-2.97M
-19.10%-2.5M
Asset Impairment Loss
23.41%-387.66K
91.30%-55.11K
878.09%422.48K
-407.10%-2.56M
-32.79%-506.15K
---633.69K
---54.3K
76.77%-504.03K
---381.16K
----
Other net revenue
-191.97%-5.48M
-173.12%-3.61M
-98.40%46.7K
561.55%16.83M
388.72%5.96M
139.11%4.94M
-24.18%2.92M
-595.33%-3.65M
81.81%1.22M
533.04%2.07M
Invest income
-275.69%-5.62M
-434.00%-4.9M
-100.65%-1.01M
85.26%-421.81K
33.26%-1.5M
7.40%-917.05K
-401.20%-502.85K
-87.82%-2.86M
-136.20%-2.24M
-38.24%-990.31K
-Including: Investment income associates
-288.00%-4.54M
-488.77%-3.96M
-16.23%-352.76K
108.17%138K
21.99%-1.17M
0.40%-673.08K
-281.79%-303.5K
-3,355.80%-1.69M
-479.18%-1.5M
-356.52%-675.81K
Asset deal income
---700
----
----
114,520.59%8.89M
----
----
----
---7.77K
----
----
Other revenue
-27.61%5.5M
-47.98%3.89M
15.52%2.75M
76.00%14.64M
11.59%7.6M
34.75%7.49M
-53.87%2.38M
48.06%8.32M
72.34%6.81M
78.29%5.56M
Operating profit
4.33%122.48M
12.62%87.25M
12.38%46.68M
-6.56%174.77M
-16.93%117.4M
-16.15%77.48M
-6.55%41.54M
19.72%187.05M
20.30%141.32M
21.76%92.4M
Add:Non operating Income
-90.17%26.1K
-90.56%25K
-90.54%25K
-45.10%1.78M
551.56%265.37K
550.15%264.79K
593.11%264.29K
-39.03%3.24M
-98.22%40.73K
-97.96%40.73K
Less:Non operating expense
-34.71%529.39K
-70.31%208.74K
-23.92%130K
23.02%1.52M
19.44%810.88K
25.74%703.08K
2.17%170.87K
-37.85%1.24M
162.57%678.9K
375.54%559.16K
Total profit
4.39%121.98M
13.02%87.07M
11.88%46.58M
-7.42%175.03M
-16.94%116.85M
-16.16%77.04M
-6.06%41.63M
18.48%189.05M
17.73%140.68M
18.14%91.89M
Less:Income tax cost
-11.17%14.44M
54.08%14.39M
45.77%9.58M
4.78%23.69M
-19.76%16.26M
-26.08%9.34M
-3.88%6.57M
15.00%22.61M
6.85%20.26M
1.14%12.63M
Net profit
6.90%107.54M
7.35%72.68M
5.53%37M
-9.07%151.34M
-16.46%100.6M
-14.58%67.7M
-6.46%35.06M
18.97%166.44M
19.78%120.42M
21.40%79.25M
Net profit from continuing operation
6.90%107.54M
7.35%72.68M
5.53%37M
-9.07%151.34M
-16.46%100.6M
-14.58%67.7M
-6.46%35.06M
18.97%166.44M
19.78%120.42M
21.40%79.25M
Less:Minority Profit
26.24%14.84M
58.61%9.79M
13.01%4.45M
-34.86%16.33M
-44.38%11.76M
-54.59%6.17M
-44.29%3.94M
19.04%25.07M
45.02%21.14M
24.76%13.6M
Net profit of parent company owners
4.34%92.7M
2.21%62.89M
4.58%32.55M
-4.50%135.01M
-10.52%88.84M
-6.29%61.53M
2.34%31.12M
18.96%141.37M
15.50%99.29M
20.72%65.66M
Earning per share
Basic earning per share
3.23%0.32
4.76%0.22
0.00%0.11
-4.08%0.47
-11.43%0.31
-8.70%0.21
0.00%0.11
19.51%0.49
16.67%0.35
21.05%0.23
Diluted earning per share
3.23%0.32
4.76%0.22
0.00%0.11
-4.08%0.47
--0.31
-8.70%0.21
0.00%0.11
19.51%0.49
----
21.05%0.23
Other composite income
-73.05K
-43.21K
-81.36K
-195.31K
Other composite income of parent company owners
---73.05K
---43.21K
---81.36K
---195.31K
----
----
----
----
----
----
Total composite income
6.83%107.47M
7.29%72.64M
5.30%36.92M
-9.19%151.15M
-16.46%100.6M
-14.58%67.7M
-6.46%35.06M
18.97%166.44M
19.78%120.42M
21.40%79.25M
Total composite income of parent company owners
4.26%92.63M
2.14%62.84M
4.32%32.46M
-4.64%134.81M
-10.52%88.84M
-6.29%61.53M
2.34%31.12M
18.96%141.37M
15.50%99.29M
20.72%65.66M
Total composite income of minority owners
26.24%14.84M
58.61%9.79M
13.01%4.45M
-34.86%16.33M
-44.38%11.76M
-54.59%6.17M
-44.29%3.94M
19.04%25.07M
45.02%21.14M
24.76%13.6M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 10.87%1.64B17.98%1.13B17.00%528.46M11.20%2.17B5.04%1.48B6.46%954.65M11.70%451.68M18.80%1.96B20.71%1.41B18.12%896.69M
Operating revenue 10.87%1.64B17.98%1.13B17.00%528.46M11.20%2.17B5.04%1.48B6.46%954.65M11.70%451.68M18.80%1.96B20.71%1.41B18.12%896.69M
Other operating revenue -----88.06%1.35M----34.37%21.46M----59.70%11.28M----41.36%15.97M-----18.18%7.06M
Total operating cost 10.54%1.52B17.39%1.04B16.65%481.82M14.26%2.02B7.84%1.37B9.40%882.11M13.55%413.07M18.40%1.76B20.80%1.27B17.97%806.35M
Operating cost 4.89%824.02M11.60%552.2M13.66%268.77M23.62%1.13B12.50%785.58M11.61%494.79M17.01%236.47M22.15%912.12M22.89%698.32M23.61%443.31M
Operating tax surcharges 14.20%14.81M20.88%10.55M15.30%4.62M8.22%19.87M3.70%12.97M9.47%8.73M25.25%4M19.59%18.36M26.68%12.5M26.76%7.98M
Operating expense 17.69%459.17M19.98%320.98M20.86%142.32M-2.09%591.6M2.73%390.14M10.36%267.53M8.24%117.76M13.52%604.24M14.48%379.77M9.08%242.41M
Administration expense 9.98%106.06M10.69%72.59M6.34%42.47M2.32%119.52M-12.40%96.44M-15.01%65.58M3.69%39.94M4.90%116.81M19.14%110.09M17.02%77.16M
Financial expense 2.43%18.23M-3.26%11.57M9.70%5.9M24.29%25.48M41.72%17.8M76.66%11.96M26.31%5.38M12.68%20.5M6.82%12.56M1.95%6.77M
-Interest expense (Financial expense) 8.22%18.91M-6.81%12.12M-0.95%5.33M5.98%26.69M3.58%17.47M24.64%13.01M13.37%5.38M31.86%25.18M30.15%16.87M34.57%10.44M
-Interest Income (Financial expense) 45.08%-582.09K45.68%-447.13K56.36%-216.13K51.48%-1.33M51.90%-1.06M51.63%-823.1K37.56%-495.25K-41.76%-2.74M-66.72%-2.2M-41.23%-1.7M
Research and development 36.61%94.32M101.59%67.58M86.38%17.74M42.95%132.14M17.14%69.04M16.70%33.52M37.90%9.52M39.06%92.44M50.66%58.94M20.69%28.73M
Credit Impairment Loss -1,461.65%-4.98M-155.76%-2.55M-292.37%-2.12M56.75%-3.71M112.32%365.45K60.08%-998.27K174.81%1.1M-610.33%-8.59M-24.99%-2.97M-19.10%-2.5M
Asset Impairment Loss 23.41%-387.66K91.30%-55.11K878.09%422.48K-407.10%-2.56M-32.79%-506.15K---633.69K---54.3K76.77%-504.03K---381.16K----
Other net revenue -191.97%-5.48M-173.12%-3.61M-98.40%46.7K561.55%16.83M388.72%5.96M139.11%4.94M-24.18%2.92M-595.33%-3.65M81.81%1.22M533.04%2.07M
Invest income -275.69%-5.62M-434.00%-4.9M-100.65%-1.01M85.26%-421.81K33.26%-1.5M7.40%-917.05K-401.20%-502.85K-87.82%-2.86M-136.20%-2.24M-38.24%-990.31K
-Including: Investment income associates -288.00%-4.54M-488.77%-3.96M-16.23%-352.76K108.17%138K21.99%-1.17M0.40%-673.08K-281.79%-303.5K-3,355.80%-1.69M-479.18%-1.5M-356.52%-675.81K
Asset deal income ---700--------114,520.59%8.89M---------------7.77K--------
Other revenue -27.61%5.5M-47.98%3.89M15.52%2.75M76.00%14.64M11.59%7.6M34.75%7.49M-53.87%2.38M48.06%8.32M72.34%6.81M78.29%5.56M
Operating profit 4.33%122.48M12.62%87.25M12.38%46.68M-6.56%174.77M-16.93%117.4M-16.15%77.48M-6.55%41.54M19.72%187.05M20.30%141.32M21.76%92.4M
Add:Non operating Income -90.17%26.1K-90.56%25K-90.54%25K-45.10%1.78M551.56%265.37K550.15%264.79K593.11%264.29K-39.03%3.24M-98.22%40.73K-97.96%40.73K
Less:Non operating expense -34.71%529.39K-70.31%208.74K-23.92%130K23.02%1.52M19.44%810.88K25.74%703.08K2.17%170.87K-37.85%1.24M162.57%678.9K375.54%559.16K
Total profit 4.39%121.98M13.02%87.07M11.88%46.58M-7.42%175.03M-16.94%116.85M-16.16%77.04M-6.06%41.63M18.48%189.05M17.73%140.68M18.14%91.89M
Less:Income tax cost -11.17%14.44M54.08%14.39M45.77%9.58M4.78%23.69M-19.76%16.26M-26.08%9.34M-3.88%6.57M15.00%22.61M6.85%20.26M1.14%12.63M
Net profit 6.90%107.54M7.35%72.68M5.53%37M-9.07%151.34M-16.46%100.6M-14.58%67.7M-6.46%35.06M18.97%166.44M19.78%120.42M21.40%79.25M
Net profit from continuing operation 6.90%107.54M7.35%72.68M5.53%37M-9.07%151.34M-16.46%100.6M-14.58%67.7M-6.46%35.06M18.97%166.44M19.78%120.42M21.40%79.25M
Less:Minority Profit 26.24%14.84M58.61%9.79M13.01%4.45M-34.86%16.33M-44.38%11.76M-54.59%6.17M-44.29%3.94M19.04%25.07M45.02%21.14M24.76%13.6M
Net profit of parent company owners 4.34%92.7M2.21%62.89M4.58%32.55M-4.50%135.01M-10.52%88.84M-6.29%61.53M2.34%31.12M18.96%141.37M15.50%99.29M20.72%65.66M
Earning per share
Basic earning per share 3.23%0.324.76%0.220.00%0.11-4.08%0.47-11.43%0.31-8.70%0.210.00%0.1119.51%0.4916.67%0.3521.05%0.23
Diluted earning per share 3.23%0.324.76%0.220.00%0.11-4.08%0.47--0.31-8.70%0.210.00%0.1119.51%0.49----21.05%0.23
Other composite income -73.05K-43.21K-81.36K-195.31K
Other composite income of parent company owners ---73.05K---43.21K---81.36K---195.31K------------------------
Total composite income 6.83%107.47M7.29%72.64M5.30%36.92M-9.19%151.15M-16.46%100.6M-14.58%67.7M-6.46%35.06M18.97%166.44M19.78%120.42M21.40%79.25M
Total composite income of parent company owners 4.26%92.63M2.14%62.84M4.32%32.46M-4.64%134.81M-10.52%88.84M-6.29%61.53M2.34%31.12M18.96%141.37M15.50%99.29M20.72%65.66M
Total composite income of minority owners 26.24%14.84M58.61%9.79M13.01%4.45M-34.86%16.33M-44.38%11.76M-54.59%6.17M-44.29%3.94M19.04%25.07M45.02%21.14M24.76%13.6M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday-1.74%
State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%
Specialized, Special and New
Specialized, Special and New
Intraday-1.91%